Clinical Trials Browser

Phase 1 × Pancreatic Neoplasms × bosutinib × Clear all

NCT01025570 2014-05-09

A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer

Phase 1 Terminated

Gastrointestinal

Pancreatic Neoplasms